When exposed to ICI, specifically anti PD1 or anti CTLA4 and anti PD1, the BRCA2mut mammal tumor exhibited a greater response, with significant growth delay, compared to the BRCA2wt cell line. This evidence concerns the gene CTLA4 and neoplasm.